TransMedics Group Inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
TMDX$93.79+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(In thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net loss | $(25,028) | $(36,231) | $(44,215) |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | 26 | (73) | (46) |
| Unrealized gains (losses) on marketable securities, net of tax of $0 | — | 36 | (47) |
| Total other comprehensive income (loss) | 26 | (37) | (93) |
| Comprehensive loss | $(25,002) | $(36,268) | $(44,308) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.